Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers biological sample analysis, packaging material compatibility, and base toxic impurity analysis. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.
Metrics to compare | 600721 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600721PeersSector | |
|---|---|---|---|---|
P/E Ratio | 71.2x | 13.5x | −0.5x | |
PEG Ratio | 0.45 | 0.03 | 0.00 | |
Price/Book | 4.5x | 2.7x | 2.6x | |
Price / LTM Sales | 9.1x | 4.4x | 3.3x | |
Upside (Analyst Target) | - | 18.4% | 47.0% | |
Fair Value Upside | Unlock | −0.9% | 5.9% | Unlock |